TickerFactsScreenerDevelopers

Celldex Therapeutics, Inc. (CLDX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$98.89M2016: -$113.04M2017: -$99.93M2018: -$75.23M2019: -$46.41M2020: -$40.40M2021: -$60.91M2022: -$103.73M2023: -$107.29M2024: -$157.78M2025: -$210.94M-$210.94M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$210.94M-33.7%
2024-$157.78M-47.1%
2023-$107.29M-3.4%
2022-$103.73M-70.3%
2021-$60.91M-50.7%
2020-$40.40M+13.0%
2019-$46.41M+38.3%
2018-$75.23M+24.7%
2017-$99.93M+11.6%
2016-$113.04M-14.3%
2015-$98.89M—